NAFDAC Recalls Deekins Amoxycillin 500mg Capsules Following Severe Adverse Reactions

By DAYO ADESULU

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a recall for a specific batch of Deekins Amoxycillin 500mg Capsules due to reports of severe adverse drug reactions.


Details of the Recalled Batch

The affected batch, identified by lot number 4C639001, was manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.

According to a statement released by NAFDAC on Wednesday via X (formerly Twitter), the recall was initiated following reports from a hospital that recorded three severe reactions in patients administered the capsules.


About Deekins Amoxycillin

Amoxicillin, a penicillin-based antibiotic, is commonly prescribed for bacterial infections such as:


NAFDAC’s Advice to Healthcare Professionals and the Public

NAFDAC has urged both healthcare professionals and consumers to:

For concerns or reports, the agency can be contacted via:


Safety Measures

This recall underscores the importance of vigilance in monitoring the safety of pharmaceuticals to protect public health. Consumers and healthcare providers are encouraged to stay alert and cooperate with NAFDAC to ensure the affected batch is swiftly removed from circulation.

Exit mobile version